APA (7th ed.) Citation

Harper-Wynne, C., & Burcombe, R. (2021). 142P Bone mineral density (BMD) after three years of adjuvant zoledronic acid (ZA) in postmenopausal oestrogen receptor positive (ER+) early breast cancer (EBC): An observational single centre study. Annals of Oncology, 32, S82. https://doi.org/10.1016/j.annonc.2021.03.156

Chicago Style (17th ed.) Citation

Harper-Wynne, C., and R. Burcombe. "142P Bone Mineral Density (BMD) After Three Years of Adjuvant Zoledronic Acid (ZA) in Postmenopausal Oestrogen Receptor Positive (ER+) Early Breast Cancer (EBC): An Observational Single Centre Study." Annals of Oncology 32 (2021): S82. https://doi.org/10.1016/j.annonc.2021.03.156.

MLA (9th ed.) Citation

Harper-Wynne, C., and R. Burcombe. "142P Bone Mineral Density (BMD) After Three Years of Adjuvant Zoledronic Acid (ZA) in Postmenopausal Oestrogen Receptor Positive (ER+) Early Breast Cancer (EBC): An Observational Single Centre Study." Annals of Oncology, vol. 32, 2021, p. S82, https://doi.org/10.1016/j.annonc.2021.03.156.